1 Min Read
Jan 4 (Reuters) - Eisai Co Ltd
* Eisai acquires all global development and marketing rights for chronic weight management treatment lorcaserin HCI Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.